3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
12
Gastrointestinal
6
Myeloid
5
Lymphoid
5
Genitourinary
5
CNS
5
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Conditions
Malignant Solid Neoplasm
2
Stomach Neoplasms
1
Solid Tumor, Adult
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pelvic Neoplasms
1
Ovarian Neoplasms
1
Mesothelioma, Malignant
1
Liposarcoma
1
Fallopian Tube Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Interventions
Cyclophosphamide
6
Thiotepa
5
Granulocyte Colony-Stimulating Factor
4
Filgrastim
4
Etoposide
4
Cisplatin
4
Busulfan
4
tislelizumab
3
Melphalan
3
Carboplatin
3
tazemetostat
2
regorafenib
2
pembrolizumab
2
belinostat
2
Topotecan
2
Temozolomide
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Mesna
2
Ifosfamide
2
Doxorubicin
2
spartalizumab
1
sodium thiosulfate
1
sargramostim
1
pegylated granulocyte colony-stimulating factor
1
fludarabine phosphate
1
fludarabine
1
etoposide phosphate
1
entinostat
1
cixutumumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma
×
X-Rays
×
Other solid neoplasm
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled